400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Epigenetics / HDAC / Citarinostat/西他司他
CAS No.: 1316215-12-9
Synonyms: ACY241;HDAC-IN-2
Citarinostat selectively inhibits HDAC6 with IC50 of 4 nM. It can also inhibit HDAC3 (IC50 = 76 nM).
生物活性
靶点 | HDAC6 IC50:4nM | HDAC3 IC50:76nM |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT02886065 | Smoldering Multiple Myeloma | Phase 1 | Recruiting | May 2021 | United States, Massachusetts ... more >> Massachusetts general Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Noopur Raje, MD 617-726-0711 Principal Investigator: Noopur Raje, MD Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02115 Contact: David Avigan, MD Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Paul Richardson, MD Collapse << |
实验方案
技术信息
CAS号 | 1316215-12-9 | 储存条件 |
|
|||||||
分子式 | C24H26ClN5O3 | 运输 | 蓝冰 | |||||||
分子量 | 467.95 | 别名 | ACY241;HDAC-IN-2 | |||||||
溶解度 |
|
动物实验配方 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT02886065 | Smoldering Multiple Myeloma | Phase 1 | Recruiting | May 2021 | United States, Massachusetts ... more >> Massachusetts general Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Noopur Raje, MD 617-726-0711 Principal Investigator: Noopur Raje, MD Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02115 Contact: David Avigan, MD Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Paul Richardson, MD Collapse << |
靶点 | Description | IC50 |
---|---|---|
HDAC6 | IC50:4nM | |
HDAC3 | IC50:76nM |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网